Literature DB >> 11208164

Regulation of receptor tyrosine kinase signaling by endocytic trafficking.

H S Wiley1, P M Burke.   

Abstract

Activated receptor tyrosine kinase (RTK) receptors are rapidly internalized and eventually delivered to the lysosomes. Although ligand-induced endocytosis was originally thought to be a mechanism of receptor inactivation, many studies suggest that receptors remain active within endosomes. This review discusses the role that internalized signaling complexes may play in different RTK systems including recent data on how ubiquitination may regulate this process. In general, it appears that some receptor systems have evolved to enhance endosomal signaling, as is the case for TrkA and NGF. In contrast, the insulin receptor system appears to limit the extent of endosomal signaling. The EGFR system is the intermediate example. In this case, some signals are specifically generated from the cell surface while others appear to be generated from within endosomes. This may act as a mechanism to produce ligand-specific signals. Thus, trafficking could play diverse roles in receptor signaling, depending on the specific cell and tissue type.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11208164     DOI: 10.1034/j.1600-0854.2001.020103.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  76 in total

1.  Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-κB signaling.

Authors:  S M Shahjahan Miah; Amanda K Purdy; Nicholas B Rodin; Alexander W MacFarlane; Jennifer Oshinsky; Diana A Alvarez-Arias; Kerry S Campbell
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

2.  Long-range signal transmission in autocrine relays.

Authors:  Michal Pribyl; Cyrill B Muratov; Stanislav Y Shvartsman
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

Review 3.  Stress-induced EGF receptor signaling through STAT3 and tumor progression in triple-negative breast cancer.

Authors:  Nikolas Balanis; Cathleen R Carlin
Journal:  Mol Cell Endocrinol       Date:  2017-01-12       Impact factor: 4.102

Review 4.  Targeting Na/K-ATPase Signaling: A New Approach to Control Oxidative Stress.

Authors:  Jiang Liu; Megan N Lilly; Joseph I Shapiro
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

Review 5.  Organelles and trafficking machinery for postsynaptic plasticity.

Authors:  Matthew J Kennedy; Michael D Ehlers
Journal:  Annu Rev Neurosci       Date:  2006       Impact factor: 12.449

6.  Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors.

Authors:  Marta Marchetti; Marie-Noelle Monier; Alexandre Fradagrada; Keith Mitchell; Florence Baychelier; Pierre Eid; Ludger Johannes; Christophe Lamaze
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

7.  Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus.

Authors:  Mads Lerdrup; Silas Bruun; Michael V Grandal; Kirstine Roepstorff; Malene M Kristensen; Anette M Hommelgaard; Bo van Deurs
Journal:  Mol Biol Cell       Date:  2007-07-11       Impact factor: 4.138

Review 8.  Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.

Authors:  Byung Min Chung; Eric Tom; Neha Zutshi; Timothy Alan Bielecki; Vimla Band; Hamid Band
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival.

Authors:  Yi Wang; Steven Pennock; Xinmei Chen; Zhixiang Wang
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  Cellular localization of the activated EGFR determines its effect on cell growth in MDA-MB-468 cells.

Authors:  Dustin C Hyatt; Brian P Ceresa
Journal:  Exp Cell Res       Date:  2008-09-11       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.